Shortage stems mostly from India's decision to stop exporting vaccines from its Serum Institute factory, which produces the overwhelming majority of the AstraZeneca doses.
from Home Page https://ift.tt/3mAeTsE
from Home Page https://ift.tt/3mAeTsE
Comments
Post a Comment